Physician profile
David A Lickstein
NPI 1275642183
$40,115.05
in general payments reported to CMS, 2019-2025
22 companies · $3,253 in 2025
The $3,253 reported for 2025 was more than what 90% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $1,027 · 2021: $2,414 · 2022: $9,454 · 2023: $1,168 · 2024: $1,214 · 2025: $3,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,589 · Long Term Medical Supply Or Device Loan: $1,799 · Honoraria: $975 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $246 · Education: $25.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,589.21 |
| Long Term Medical Supply Or Device Loan | $1,798.77 |
| Honoraria | $975.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $246.40 |
| Education | $25.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $31,260.98 | 2019-2022 | |
| Integra Lifesciences Corporation | $2,162.52 | 2022-2025 | Durasorb Monofilament Mesh, Cytal, Integra |
| Abbvie INC. | $1,432.05 | 2023-2025 | |
| Sientra, INC. | $1,411.03 | 2019-2022 | |
| Becton, Dickinson and Company | $975.00 | 2025 | |
| Davol INC. | $478.79 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $401.94 | 2019-2024 | |
| Tela Bio, INC. | $365.35 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Merz North America, INC. | $336.73 | 2019-2022 | |
| Dilon Technologies, INC. | $334.13 | 2022-2024 | Hemoblast Bellows |
| Bard Peripheral Vascular, INC. | $312.77 | 2021 | |
| Galderma Laboratories, L.P. | $259.65 | 2019-2024 | Dysport |
| Revance Therapeutics, INC. | $79.46 | 2024 | Daxxify |
| Kerecis Limited | $78.84 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Solta Medical, A Division of Bausch Health US, LLC | $51.45 | 2022-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $40.89 | 2024 | Stravix, Grafix, Oasis |
| Mentor Worldwide LLC | $29.16 | 2022-2024 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Lilly USA, LLC | $26.48 | 2019-2020 | |
| Motiva USA, LLC | $24.86 | 2025 | |
| Vioptix INC | $21.95 | 2024 | T. Ox Tissue Oximeter |
| Ethicon US, LLC | $19.00 | 2022 | |
| Amgen INC. | $12.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lickstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.